Modular DNA barcoding of nanobodies enables multiplexed in situ protein imaging and high-throughput biomolecule detection
eLife · 22.07.2025 · 14
DOI: 10.7554/elife.105225 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 22.07.2025. Verfasst von Shilin Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Single-Domain Antibodies, SARS-CoV-2, DNA Barcoding, Taxonomic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Brain Initiative, Beijing Nova Program.
Abstract (Originalsprache)
Current immunodetection methods using antibody-DNA conjugates enable multiplexed target detection through orthogonal DNA barcodes, but existing conjugation approaches are labor-intensive and often compromise antibody function. Here, we present a modular, site-specific, and cost-efficient DNA tagging strategy – multiplexed and modular barcoding of antibodies (MaMBA). Utilizing nanobodies as modular adaptors, MaMBA enables direct site-specific labeling of off-the-shelf IgG antibodies with a one-component design. We first applied MaMBA to develop the MaMBA-assisted immunosignal hybridization chain reaction ( mis HCR) method for highly multiplexed in situ protein imaging via orthogonal HCR. Its cleavable variant, mis HCR n , achieves simultaneous visualization of 12 different targets within the same mouse brain sections through iterative probe use. We further extended the cleavable MaMBA to develop the barcode-linked immunosorbent assay (BLISA) for multiplexed and high-throughput biomolecule detections. By combining BLISA with next-generation sequencing, we successfully measured SARS-CoV-2 IgG and hepatitis B virus (HBV)-associated antigens in a large number of human serum samples. Additionally, we demonstrated a small-scale drug screen by using BLISA to simultaneously detect eight protein targets. In conclusion, MaMBA offers a highly modular and easily adaptable approach for antibody DNA barcoding, which can be broadly applied in basic research and clinical diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Peking University, Beijing, China.
- National Institute of Biological Sciences (NIBS), Beijing, China.
- Peking University-Tsinghua University-National Institute of Biological Sciences Joint Graduate Program, NIBS, Beijing, China.
- Chinese Institute for Brain Research, Beijing, China.
- School of Biomedical Engineering, Capital Medical University, Beijing, China.
- Tsinghua Institute of Multidisciplinary Biomedical Research (TIMBR), Beijing, China.
ORCID-Profile: Shilin Zhong, Ruiyu Wang, Rui Lin, Minmin Luo
Förderung
- National Natural Science Foundation of China
- China Brain Initiative
- Beijing Nova Program
- Chinese Academy of Medical Sciences
- New Cornerstone Investigator Program
Zitieren
APA
Zhong, S., Wang, R., Gao, X., Guo, Q., Lin, R., & Luo, M. (2025). Modular DNA barcoding of nanobodies enables multiplexed in situ protein imaging and high-throughput biomolecule detection. eLife, 14. https://doi.org/10.7554/elife.105225
Vancouver
Zhong S, Wang R, Gao X, Guo Q, Lin R, Luo M. Modular DNA barcoding of nanobodies enables multiplexed in situ protein imaging and high-throughput biomolecule detection. eLife. 2025;14. doi:10.7554/elife.105225
BibTeX
@article{Zhong2025,
author = {Zhong, Shilin and Wang, Ruiyu and Gao, Xinwei and Guo, Qingchun and Lin, Rui and Luo, Minmin},
title = {Modular DNA barcoding of nanobodies enables multiplexed in situ protein imaging and high-throughput biomolecule detection},
journal = {eLife},
year = {2025},
volume = {14},
doi = {10.7554/elife.105225}
}
EUVIMED